The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome

Table 4

Treatment outcome of the control group (n = 31).

After (month)	PASI (before treatment (X ± SD)	PASI (after treatment) (X ± SD)	% Reduction
1	22.3 ± 18.3	18.1 ± 14.5	19.28	0.31
2		14.1 ± 10.9	36.78	0.03
3		11.1 ± 8.6	50.22	0.002

Note. Mean PASI decreased each month. After three months of treatment, the mean PASI dropped by 50.22%. There was a statistically significant difference in PASI before and after treatment (, Student t-test).